Article Details
Retrieved on: 2021-10-08 16:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca's tezelpelumab was granted orphan drug designation by FDA for the treatment of eosinophilic esophagitis. Astrazeneca announced on Oct. 8, ...
Article found on: www.biopharminternational.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here